ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹466 Cr | ₹757 Cr | ₹67 Cr | ₹33 Cr | ₹23 Cr |
What is the latest Total Non-Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹757 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹23 Cr |
How is Total Non-Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹466 Cr | -38.43 | |
| Mar2024 | ₹757 Cr | 1,023.14 | |
| Mar2023 | ₹67 Cr | 106.11 | |
| Mar2022 | ₹33 Cr | 42.87 | |
| Mar2021 | ₹23 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹11,213.6 Cr | 0.1% | -2.7% | 2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 0.1% |
-2.7% |
2.6% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses